Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Homoharringtonine

EU orphan designation number: EU/3/04/224   
Active ingredient: Homoharringtonine
Indication: Treatment of chronic myeloid leukaemia
Sponsor: Teva Pharma GmbH
Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/09/2004 Centralised Orphan - Designation EMEA/OD/041/04 (2004)3426 of 02/09/2004
25/11/2008 Other procedure
08/01/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/041/04/T/01 (2009)19 of 05/01/2009
13/12/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/041/04/T/02 (2012)9405 of 06/12/2012